| [1] |
Campbell B C V, De Silva D A, Macleod M R, et al. Ischaemic stroke[J]. Nat Rev Dis Primers, 2019, 5(1): 70.
|
| [2] |
Grotta J C. Fifty years of acute ischemic stroke treatment: a personal history[J]. Cerebrovasc Dis, 2021, 50(6): 666-680.
|
| [3] |
Feske S K. Ischemic stroke[J]. Am J Med, 2021, 134(12): 1457-1464.
|
| [4] |
Jolugbo P, Ariëns R A S. Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke[J]. Stroke, 2021, 52(3): 1131-1142.
|
| [5] |
Chan P H. Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia[J]. Neurochem Res, 2004, 29(11): 1943-1949.
|
| [6] |
Yang Y, Rosenberg G A. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease[J]. Stroke, 2011, 42(11): 3323-3328.
|
| [7] |
Ho-Tin-Noé B, Desilles J P, Mazighi M. Thrombus composition and thrombolysis resistance in stroke[J]. Res Pract Thromb Haemost, 2023, 7(4): 100178. DOI: 10.1016/j.rpth.2023.100178.
|
| [8] |
Paul S, Candelario-Jalil E. Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies[J]. Exp Neurol, 2021, 335: 113518.
|
| [9] |
Wu X W, Deng X E, Wang J D, et al. Baicalin inhibits cell proliferation and inflammatory cytokines induced by tumor necrosis factor α (TNF-α) in human immortalized keratinocytes (HaCaT) human keratinocytes by inhibiting the STAT3/nuclear factor kappa B (NF-κB) signaling pathway[J]. Med Sci Monit, 2020, 26: e919392.
|
| [10] |
Guo L T, Wang S Q, Su J, et al. Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K/AKT/FoxO1 pathway[J]. J Neuroinflammation, 2019, 16(1): 95.
|
| [11] |
Duan L N, Zhang Y, Yang Y N, et al. Baicalin inhibits ferroptosis in intracerebral hemorrhage[J]. Front Pharmacol, 2021, 12: 629379.
|
| [12] |
Huang Z X, Guo L, Huang L J, et al. Baicalin-loaded macrophage-derived exosomes ameliorate ischemic brain injury via the antioxidative pathway[J]. Mater Sci Eng C Mater Biol Appl, 2021, 126: 112123. DOI: 10.1016/j.msec.2021.112123.
|
| [13] |
Hao Z Y, Zhang Z Y, Zhao Y H, et al. Baicalin reduces immune cell infiltration by inhibiting inflammation and protecting tight junctions in ischemic stroke injury[J]. Am J Chin Med, 2023, 51(2): 355-372.
|
| [14] |
Chang W T, Shao Z H, Yin J J, et al. Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes[J]. Eur J Pharmacol, 2007, 566(1/2/3): 58-66.
|
| [15] |
Jung S H, Kang K D, Ji D, et al. The flavonoid baicalin counteracts ischemic and oxidative insults to retinal cells and lipid peroxidation to brain membranes[J]. Neurochem Int, 2008, 53(6/7/8): 325-337. DOI: 10.1016/j.neuint.2008.09.004.
|
| [16] |
Lombardozzi G, Castelli V, Giorgi C,et al. Neuroinflammation strokes the brain: a double-edged sword in ischemic stroke[J]. Neural Regeneration Research, 2026, 21(5): 1715-1722. DOI: 10.4103/NRR.NRR-D-24-01456.
|
| [17] |
Alsbrook D L, Di Napoli M, Bhatia K, et al. Neuroinflammation in acute ischemic and hemorrhagic stroke[J]. Curr Neurol Neurosci Rep, 2023, 23(8): 407-431.
|
| [18] |
Jurcau A, Ardelean I A. Molecular pathophysiological mechanisms of ischemia/reperfusion injuries after recanalization therapy for acute ischemic stroke[J]. J Integr Neurosci, 2021, 20(3): 727-744.
|
| [19] |
Chen Y F, Wang Y W, Huang W S, et al. Trans-cinnamaldehyde, an essential oil in cinnamon powder, ameliorates cerebral ischemia-induced brain injury via inhibition of neuroinflammation through attenuation of iNOS, COX-2 expression and NFκ-B signaling pathway[J]. Neuromolecular Med, 2016, 18(3): 322-333. DOI: 10.1007/s12017-016-8395-9.
|
| [20] |
Li T, Xu T, Zhao J, et al. Depletion of iNOS-positive inflammatory cells decelerates neuronal degeneration and alleviates cerebral ischemic damage by suppressing the inflammatory response[J]. Free Radic Biol Med, 2022, 181: 209-220.
|
| [21] |
Candelario-Jalil E, González-Falcón A, García-Cabrera M, et al. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat[J]. Brain Res, 2004, 1007(1/2): 98-108.
|
| [22] |
Chen S P, Peng J H, Sherchan P, et al. TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K/Akt pathway after intracerebral hemorrhage in mice[J]. J Neuroinflammation, 2020, 17(1): 168.
|
| [23] |
Yan J, Zhang Y, Wang L, et al. TREM2 activation alleviates neural damage via Akt/CREB/BDNF signalling after traumatic brain injury in mice[J]. J Neuroinflammation, 2022, 19(1): 289.
|
| [24] |
Deczkowska A, Weiner A, Amit I. The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway[J]. Cell, 2020, 181(6): 1207-1217.
|
| [25] |
Wang H X, Ma J L, Li X L, et al. FDA compound library screening Baicalin upregulates TREM2 for the treatment of cerebral ischemia-reperfusion injury[J]. Eur J Pharmacol, 2024, 969: 176427.
|
| [26] |
Barton G M, Medzhitov R. Toll-like receptor signaling pathways[J]. Science, 2003, 300(5625): 1524-1525.
|
| [27] |
Tang S C, Arumugam T V, Xu X R, et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits[J]. Proc Natl Acad Sci U S A, 2007, 104(34): 13798-13803.
|
| [28] |
Tu X K, Yang W Z, Shi S S, et al. Spatio-temporal distribution of inflammatory reaction and expression of TLR2/4 signaling pathway in rat brain following permanent focal cerebral ischemia[J]. Neurochem Res, 2010, 35(8): 1147-1155.
|
| [29] |
Ridder D A, Schwaninger M. NF-kappaB signaling in cerebral ischemia[J]. Neuroscience, 2009, 158(3): 995-1006.
|
| [30] |
Li H Y, Yuan Z Y, Wang Y G, et al. Role of baicalin in regulating Toll-like receptor 2/4 after ischemic neuronal injury[J]. Chin Med J, 2012, 125(9): 1586-1593.
|
| [31] |
Xue X, Qu X J, Yang Y, et al. Baicalin attenuates focal cerebral ischemic reperfusion injury through inhibition of nuclear factor κB p65 activation[J]. Biochem Biophys Res Commun, 2010, 403(3/4): 398-404.
|
| [32] |
Du L X, Wang Y Q, Hua G Q, et al. IL-33/ST2 pathway as a rational therapeutic target for CNS diseases[J]. Neuroscience, 2018, 369: 222-230.
|
| [33] |
Liu J Y, Xing Y Q, Gao Y, et al. Changes in serum interleukin-33 levels in patients with acute cerebral infarction[J]. J Clin Neurosci, 2014, 21(2): 298-300. DOI: 10.1016/j.jocn.2013.04.036.
|
| [34] |
孙玥光, 范洋溢, 高旭光. 基于IL-33/ST2L通路研究黄芩苷对缺血性脑卒中大鼠的神经保护作用[J]. 中国免疫学杂志, 2023, 39(6): 1258-1263.
|
| [35] |
Samarghandian S, Azimi-Nezhad M, Farkhondeh T, et al. Anti-oxidative effects of curcumin on immobilization-induced oxidative stress in rat brain, liver and kidney[J]. Biomed Pharmacother, 2017, 87: 223-229.
|
| [36] |
Liu C, Wu J L, Gu J, et al. Baicalein improves cognitive deficits induced by chronic cerebral hypoperfusion in rats[J]. Pharmacol Biochem Behav, 2007, 86(3): 423-430.
|
| [37] |
Janyou A, Wicha P, Jittiwat J, et al. Dihydrocapsaicin attenuates blood brain barrier and cerebral damage in focal cerebral ischemia/reperfusion via oxidative stress and inflammatory[J]. Sci Rep, 2017, 7(1): 10556. DOI: 10.1038/s41598-017-11181-5.
|
| [38] |
Chen Z C, Zhong C J. Oxidative stress in Alzheimer's disease[J]. Neurosci Bull, 2014, 30(2): 271-281.
|
| [39] |
Tonelli C, Chio I I C, Tuveson D A. Transcriptional regulation by Nrf2[J]. Antioxid Redox Signal, 2018, 29(17): 1727-1745.
|
| [40] |
Shang Y, Zhou Q, Wang T T, et al. Airborne nitro-PAHs induce Nrf2/ARE defense system against oxidative stress and promote inflammatory process by activating PI3K/Akt pathway in A549 cells[J]. Toxicol In Vitro, 2017, 44: 66-73.
|
| [41] |
Chen B, Lu Y R, Chen Y N, et al. The role of Nrf2 in oxidative stress-induced endothelial injuries[J]. J Endocrinol, 2015, 225(3): R83-R99. DOI: 10.1530/JOE-14-0662.
|
| [42] |
Cao Y G, Mao X Y, Sun C Y, et al. Baicalin attenuates global cerebral ischemia/reperfusion injury in gerbils via anti-oxidative and anti-apoptotic pathways[J]. Brain Res Bull, 2011, 85(6): 396-402.
|
| [43] |
Heo J H, Han S W, Lee S K. Free radicals as triggers of brain edema formation after stroke[J]. Free Radic Biol Med, 2005, 39(1): 51-70.
|
| [44] |
Szabó C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics[J]. Nat Rev Drug Discov, 2007, 6(8): 662-680. DOI: 10.1038/nrd2222.
|
| [45] |
Radi R. Nitric oxide, oxidants, and protein tyrosine nitration[J]. Proc Natl Acad Sci U S A, 2004, 101(12): 4003-4008.
|
| [46] |
Gürsoy-Ozdemir Y, Can A, Dalkara T. Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia[J]. Stroke, 2004, 35(6): 1449-1453.
|
| [47] |
Takizawa S, Aratani Y, Fukuyama N, et al. Deficiency of myeloperoxidase increases infarct volume and nitrotyrosine formation in mouse brain[J]. J Cereb Blood Flow Metab, 2002, 22(1): 50-54.
|
| [48] |
Chen X M, Chen H S, Xu M J, et al. Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury[J]. Acta Pharmacol Sin, 2013, 34(1): 67-77.
|
| [49] |
Xu M J, Chen X M, Gu Y, et al. Baicalin can scavenge peroxynitrite and ameliorate endogenous peroxynitrite-mediated neurotoxicity in cerebral ischemia-reperfusion injury[J]. J Ethnopharmacol, 2013, 150(1): 116-124.
|
| [50] |
Liesa M, Palacín M, Zorzano A. Mitochondrial dynamics in mammalian health and disease[J]. Physiol Rev, 2009, 89(3): 799-845.
|
| [51] |
Mao C P, Zhang J J, Lin S C, et al. MiRNA-30a inhibits AECs-Ⅱ apoptosis by blocking mitochondrial fission dependent on Drp-1[J]. J Cell Mol Med, 2014, 18(12): 2404-2416.
|
| [52] |
Koshiba T, Detmer S A, Kaiser J T, et al. Structural basis of mitochondrial tethering by mitofusin complexes[J]. Science, 2004, 305(5685): 858-862. DOI: 10.1126/science.1099793.
|
| [53] |
Willems P H G M, Rossignol R, Dieteren C E J, et al. Redox homeostasis and mitochondrial dynamics[J]. Cell Metab, 2015, 22(2): 207-218. DOI: 10.1016/j.cmet.2015.06.006.
|
| [54] |
Yamazaki Y, Ogihara S, Harada S, et al. Activation of cerebral sodium-glucose transporter type 1 function mediated by post-ischemic hyperglycemia exacerbates the development of cerebral ischemia[J]. Neuroscience, 2015, 310: 674-685.
|
| [55] |
Accordi B, Galla L, Milani G, et al. AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells[J]. Leukemia, 2013, 27(5): 1019-1027.
|
| [56] |
Li S S, Sun X X, Xu L X, et al. Baicalin attenuates in vivo and in vitro hyperglycemia-exacerbated ischemia/reperfusion injury by regulating mitochondrial function in a manner dependent on AMPK[J]. Eur J Pharmacol, 2017, 815: 118-126.
|
| [57] |
Rodrigues T B, Valette J, Bouzier-Sore A K.(13)C NMR spectroscopy applications to brain energy metabolism[J]. Front Neuroenergetics, 2013, 5: 9.
|
| [58] |
Stacpoole P W. Therapeutic targeting of the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase(PDC/PDK)axis in cancer[J]. J Natl Cancer Inst, 2017, 109(11): 102.
|
| [59] |
Wang X X, Shen X Y, Yan Y T, et al. Pyruvate dehydrogenase kinases(PDKs): an overview toward clinical applications[J]. Biosci Rep, 2021, 41(4): BSR20204402.
|
| [60] |
Neil Granger D, Kvietys P R. Reperfusion injury and reactive oxygen species: The evolution of a concept[J]. Redox Biol, 2015, 6: 524-551. DOI: 10.1016/j.redox.2015.08.020.
|
| [61] |
Beach T E, Prag H A, Pala L, et al. Targeting succinate dehydrogenase with malonate ester prodrugs decreases renal ischemia reperfusion injury[J]. Redox Biol, 2020, 36: 101640.
|
| [62] |
He Z, Ning N Y, Zhou Q X, et al. Mitochondria as a therapeutic target for ischemic stroke[J]. Free Radic Biol Med, 2020, 146: 45-58.
|
| [63] |
Song X R, Gong Z X, Liu K L, et al. Baicalin combats glutamate excitotoxicity via protecting glutamine synthetase from ROS-induced 20S proteasomal degradation[J]. Redox Biol, 2020, 34: 101559.
|
| [64] |
Liu K L, Zhou Y, Song X R, et al. Baicalin attenuates neuronal damage associated with SDH activation and PDK2-PDH axis dysfunction in early reperfusion[J]. Phytomedicine, 2024, 129: 155570. DOI: 10.1016/j.phymed.2024.155570.
|
| [65] |
Orike N, Middleton G, Borthwick E, et al. Role of PI 3-kinase, Akt and Bcl-2-related proteins in sustaining the survival of neurotrophic factor-independent adult sympathetic neurons[J]. J Cell Biol, 2001, 154(5): 995-1005.
|
| [66] |
Lucendo E, Sancho M, Lolicato F, et al. Mcl-1 and Bok transmembrane domains: unexpected players in the modulation of apoptosis[J]. Proc Natl Acad Sci U S A, 2020, 117(45): 27980-27988. DOI: 10.1073/pnas.2008885117.
|
| [67] |
Cao X L, Hu X M, Hu J Q, et al. Myocardin-related transcription factor-a promoting neuronal survival against apoptosis induced by hypoxia/ischemia[J]. Brain Res, 2011, 1385: 263-274.
|
| [68] |
Knöll B, Nordheim A. Functional versatility of transcription factors in the nervous system: the SRF paradigm[J]. Trends Neurosci, 2009, 32(8): 432-442. DOI: 10.1016/j.tins.2009.05.004.
|
| [69] |
Zheng W X, Cao X L, Wang F, et al. Baicalin inhibiting cerebral ischemia/hypoxia-induced neuronal apoptosis via MRTF-A-mediated transactivity[J]. Eur J Pharmacol, 2015, 767: 201-210.
|
| [70] |
Coultrap S J, Vest R S, Ashpole N M, et al. CaMKII in cerebral ischemia[J]. Acta Pharmacol Sin, 2011, 32(7): 861-872.
|
| [71] |
Burch A M, Garcia J D, O'Leary H, et al. TRPM2 and CaMKⅡ signaling drives excessive GABAergic synaptic inhibition following ischemia[J]. J Neurosci, 2024, 44(19): e1762232024.
|
| [72] |
Wang P, Cao Y G, Yu J, et al. Baicalin alleviates ischemia-induced memory impairment by inhibiting the phosphorylation of CaMKⅡ in hippocampus[J]. Brain Res, 2016, 1642: 95-103.
|
| [73] |
Lu M L, Tang F T, Zhang J, et al. Astragaloside Ⅳ attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway[J]. Phytother Res, 2015, 29(4): 599-606.
|
| [74] |
Zhou Q B, Ju X N, Wang X Y, et al. Pretreatment with baicalin attenuates hypoxia and glucose deprivation-induced injury in SH-SY5Y cells[J]. Chin J Integr Med, 2016, 22(3): 201-206.
|
| [75] |
Manabat C, Han B H, Wendland M, et al. Reperfusion differentially induces caspase-3 activation in ischemic core and penumbra after stroke in immature brain[J]. Stroke, 2003, 34(1): 207-213.
|
| [76] |
Matsumoto T, Rauskolb S, Polack M, et al. Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF[J]. Nat Neurosci, 2008, 11(2): 131-133.
|
| [77] |
罗晨, 张华, 欧阳侃. 黄芩苷对氧糖剥夺再复氧损伤模型大鼠海马神经干细胞的保护作用[J]. 浙江中西医结合杂志, 2021, 31(3): 216-220.
|
| [78] |
Qiu Z, Lei S Q, Zhao B, et al. NLRP3 inflammasome activation-mediated pyroptosis aggravates myocardial ischemia/reperfusion injury in diabetic rats[J]. Oxid Med Cell Longev, 2017, 2017: 9743280. DOI: 10.1155/2017/9743280.
|
| [79] |
An P P, Xie J, Qiu S, et al. Hispidulin exhibits neuroprotective activities against cerebral ischemia reperfusion injury through suppressing NLRP3-mediated pyroptosis[J]. Life Sci, 2019, 232: 116599. DOI: 10.1016/j.lfs.2019.116599.
|
| [80] |
Yu C, He Q, Zheng J, et al. Sulforaphane improves outcomes and slows cerebral ischemic/reperfusion injury via inhibition of NLRP3 inflammasome activation in rats[J]. Int Immunopharmacol, 2017, 45: 74-78. DOI: 10.1016/j.intimp.2017.01.034.
|
| [81] |
PINEDA-RAMÍREZ N, GUTIÉRREZ AGUILAR G F, ESPINOZA-ROJO M, et al. Current evidence for AMPK activation involvement on resveratrol-induced neuroprotection in cerebral ischemia[J]. Nutr Neurosci, 2018, 21(4): 229-247.
|
| [82] |
Cordero M D, Williams M R, Ryffel B. AMP-activated protein kinase regulation of the NLRP3 inflammasome during aging[J]. Trends Endocrinol Metab, 2018, 29(1): 8-17.
|
| [83] |
Zheng W X, He W Q, Zhang Q R, et al. Baicalin inhibits NLRP3 inflammasome activity via the AMPK signaling pathway to alleviate cerebral ischemia-reperfusion injury[J]. Inflammation, 2021, 44(5): 2091-2105. DOI: 10.1007/s10753-021-01486-z.
|
| [84] |
Correale J, Villa A. Cellular elements of the blood-brain barrier[J]. Neurochem Res, 2009, 34(12): 2067-2077.
|
| [85] |
Bang O Y, Buck B H, Saver J L, et al. Prediction of hemorrhagic transformation after recanalization therapy using T2 *-permeability magnetic resonance imaging[J]. Ann Neurol, 2007, 62(2): 170-176. DOI: 10.1002/ana.21174.
|
| [86] |
Hoffmann A, Dege T, Kunze R, et al. Early blood-brain barrier disruption in ischemic stroke initiates multifocally around capillaries/venules[J]. Stroke, 2018, 49(6): 1479-1487.
|
| [87] |
Chen H S, Guan B H, Shen J G. Targeting ONOO -/HMGB1/MMP-9 signaling cascades: potential for drug development from Chinese medicine to attenuate ischemic brain injury and hemorrhagic transformation induced by thrombolytic treatment[J]. Integr Med Int, 2016, 3(1/2): 32-52. DOI: 10.1159/000442468.
|
| [88] |
Chen H S, Chen X M, Feng J H, et al. Peroxynitrite decomposition catalyst reduces delayed thrombolysis-induced hemorrhagic transformation in ischemia-reperfused rat brains[J]. CNS Neurosci Ther, 2015, 21(7): 585-590.
|
| [89] |
Romanos E, Planas A M, Amaro S, et al. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke[J]. J Cereb Blood Flow Metab, 2007, 27(1): 14-20. DOI: 10.1038/sj.jcbfm.9600312.
|
| [90] |
Chen H S, Guan B H, Chen X, et al. Baicalin attenuates blood-brain barrier disruption and hemorrhagic transformation and improves neurological outcome in ischemic stroke rats with delayed t-PA treatment: involvement of ONOO--MMP-9 pathway[J]. Transl Stroke Res, 2018, 9(5): 515-529.
|
| [91] |
Liu Z W, Chopp M. Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke[J]. Prog Neurobiol, 2016, 144: 103-120.
|
| [92] |
Sun L L, Zhang Y X, Liu E, et al. The roles of astrocyte in the brain pathologies following ischemic stroke[J]. Brain Inj, 2019, 33(6): 712-716.
|
| [93] |
Liu W, Wang X H, O'Connor M, et al. Brain-derived neurotrophic factor and its potential therapeutic role in stroke comorbidities[J]. Neural Plast, 2020, 2020: 1969482.
|
| [94] |
Li C X, Sui C L, Wang W, et al. Baicalin attenuates oxygen-glucose deprivation/reoxygenation-induced injury by modulating the BDNF-TrkB/PI3K/Akt and MAPK/Erk1/2 signaling axes in neuron-astrocyte cocultures[J]. Front Pharmacol, 2021, 12: 599543.
|
| [95] |
Benfenati V, Caprini M, Dovizio M, et al. An aquaporin-4/transient receptor potential vanilloid 4(AQP4/TRPV4)complex is essential for cell-volume control in astrocytes[J]. Proc Natl Acad Sci USA, 2011, 108(6): 2563-2568.
|
| [96] |
Papadopoulos M C, Verkman A S. Aquaporin-4 and brain edema[J]. Pediatr Nephrol, 2007, 22(6): 778-784.
|
| [97] |
Tureckova J, Hermanova Z, Marchetti V, et al. Astrocytic TRPV4 channels and their role in brain ischemia[J]. Int J Mol Sci, 2023, 24(8): 7101. DOI: 10.3390/ijms24087101.
|
| [98] |
郑晓宇, 宋文婷, 张业昊, 等. 黄芩苷通过抑制星形胶质细胞TRPV4和AQP4治疗脑缺血再灌注引起的大鼠脑水肿[J]. 中国中药杂志, 2022, 47(4): 1031-1038.
|
| [99] |
Chamorro Á, Dirnagl U, Urra X, et al. Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation[J]. Lancet Neurol, 2016, 15(8): 869-881.
|
| [100] |
Nagy Z, Nardai S. Cerebral ischemia/repefusion injury: from bench space to bedside[J]. Brain Res Bull, 2017, 134: 30-37.
|
| [101] |
Rose C F, Verkhratsky A, Parpura V. Astrocyte glutamine synthetase: pivotal in health and disease[J]. Biochem Soc Trans, 2013, 41(6): 1518-1524.
|